KR850000468A - 사이클릭 펩타이드의 제조방법 - Google Patents

사이클릭 펩타이드의 제조방법 Download PDF

Info

Publication number
KR850000468A
KR850000468A KR1019840000444A KR840000444A KR850000468A KR 850000468 A KR850000468 A KR 850000468A KR 1019840000444 A KR1019840000444 A KR 1019840000444A KR 840000444 A KR840000444 A KR 840000444A KR 850000468 A KR850000468 A KR 850000468A
Authority
KR
South Korea
Prior art keywords
formula
preparing
iii
compound
carboxylic acid
Prior art date
Application number
KR1019840000444A
Other languages
English (en)
Inventor
프레드리히 액셀 (외 4)
Original Assignee
하인리히 벡커 베른하르트 벡크
훽스트 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인리히 벡커 베른하르트 벡크, 훽스트 아크티엔 게젤샤프트 filed Critical 하인리히 벡커 베른하르트 벡크
Publication of KR850000468A publication Critical patent/KR850000468A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)

Abstract

내용 없음.

Description

사이클릭 펩타이드의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 일반식(IV)의 선상 헥사펩타이드를 페환시킨 다음 존재하는 보호 그룹을 제거함을 특징으로 하여 일반식(III)의 화합물 및 이의 생리학적으로 무독한 산과의 염을 제조하는 방법.
    상기식에서, X는 일반식(여기서 A 및 B는 같거나 다르며, C1내지 C3의 알킬이거나 A 및 B가 함께 C3내지 C6의 포화, 불포화 또는 방향족 모노사이클릭 또는 비사이클릭 구조를 나타내고, n은 0 또는 1임)의 L-아미노산 라디칼이고, Y는 하이드록실화될 수 있는 지방족 또는 방향족 L-아미노산의 측쇄이며, R1은 ε-아미노 그룹에 대한 보호그룹이고, 6개의 a기중 5개의 a는 화학 결합을 나타내고, 나머지 1개의 a는-OH+H-를 나타낸다.
  2. 제1항에 있어서, Y가 Thr인 일반식(III)의 화합물을 제조하는 방법.
  3. 제1항에 있어서, X가 테트라하이드로 이소퀴놀린-3-L-카복실산 라디칼인 일반식(III)의 화합물을 제조하는 방법.
  4. 제1항에 있어서, X가 시스, 엔도-옥타하이드로-[1H]-인돌-2-L-카복실산 라디칼인 일반식(III)의 화합물을 제조하는 방법.
  5. 제1항에 있어서, X가 시스, 엔도-옥타하이드로시클로펜타 [b] 피롤-2-L-카복실산인 일반식(III)의 화합물을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840000444A 1983-02-02 1984-01-31 사이클릭 펩타이드의 제조방법 KR850000468A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3303345.5 1983-02-02
DE19833303345 DE3303345A1 (de) 1983-02-02 1983-02-02 Cyclische peptide mit somatostatin-wirkung

Publications (1)

Publication Number Publication Date
KR850000468A true KR850000468A (ko) 1985-02-27

Family

ID=6189751

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840000444A KR850000468A (ko) 1983-02-02 1984-01-31 사이클릭 펩타이드의 제조방법

Country Status (15)

Country Link
US (1) US4621073A (ko)
EP (1) EP0117447B1 (ko)
JP (1) JPS59141549A (ko)
KR (1) KR850000468A (ko)
AT (1) ATE31314T1 (ko)
AU (1) AU566208B2 (ko)
CA (1) CA1245638A (ko)
DE (2) DE3303345A1 (ko)
DK (1) DK45784A (ko)
ES (1) ES529301A0 (ko)
GR (1) GR79752B (ko)
IE (1) IE56718B1 (ko)
IL (1) IL70848A (ko)
PT (1) PT78046B (ko)
ZA (1) ZA84739B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
US4612366A (en) * 1985-06-17 1986-09-16 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
US5965694A (en) * 1992-09-01 1999-10-12 The Trustees Of The University Of Pennsylvania Somatostatin mimics and synthetic methods therefor
US5700905A (en) * 1992-09-01 1997-12-23 The Trustees Of The University Of Pennsylvania Synthetic somatostatin mimics
US6001960A (en) * 1992-09-01 1999-12-14 The Trustees Of The University Of Pennsylvania Synthetic somatostatin mimics
GB0318682D0 (en) * 2003-08-08 2003-09-10 Novartis Ag Organic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303583A (en) * 1979-08-13 1981-12-01 American Home Products Corporation 1H,5H-[1,4]Thiazepino[4,3-a]indole-1,5-diones
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
NZ195303A (en) * 1979-10-31 1984-10-19 Merck & Co Inc Cyclic hexapeptide somatostatin analogues,and pharmaceutical compositions
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs

Also Published As

Publication number Publication date
AU566208B2 (en) 1987-10-15
PT78046B (de) 1986-07-15
IL70848A (en) 1987-10-30
DE3468031D1 (en) 1988-01-21
ES8500219A1 (es) 1984-10-01
EP0117447B1 (de) 1987-12-09
CA1245638A (en) 1988-11-29
ES529301A0 (es) 1984-10-01
DK45784A (da) 1984-08-03
US4621073A (en) 1986-11-04
AU2399784A (en) 1984-08-09
DK45784D0 (da) 1984-02-01
PT78046A (de) 1984-03-01
ATE31314T1 (de) 1987-12-15
EP0117447A1 (de) 1984-09-05
IE56718B1 (en) 1991-11-20
IL70848A0 (en) 1984-05-31
JPS59141549A (ja) 1984-08-14
GR79752B (ko) 1984-10-31
ZA84739B (en) 1984-09-26
DE3303345A1 (de) 1984-08-02
IE840243L (en) 1984-08-02

Similar Documents

Publication Publication Date Title
ATE113272T1 (de) Verfahren zur stabilisierung einer festen pharmazeutischen zubereitungsform von cyclischen aminosäuren.
KR900007837A (ko) 퀴누클리딘, 약제로서 이의 용도 및 이의 제조방법
KR850005454A (ko) 환상 폴리펩타이드의 제조방법
ATE99281T1 (de) Verfahren zur herstellung von 7-substituierten hept-6-en- und heptansaeuren und derivaten davon.
DE68922405D1 (de) Deletionsanaloga von magaininpeptiden.
ATE64526T1 (de) Zubereitung von pregnanolol in einer stabilen oel- in-wasser-emulsion.
KR850000468A (ko) 사이클릭 펩타이드의 제조방법
KR910016767A (ko) 신규한 펩티드
KR870000356A (ko) 메티오닐 단백질로부터 n-말단 메티오닌을 제거하는 방법
DE69633391D1 (de) KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT
KR870003097A (ko) (+)-6-클로로-5,10-디하이드로-5-[(1-메틸-4-피페리디닐)아세틸]-11H-디벤조 [b,e][1,4] 디아제핀-11-온의 분리방법
GB1514389A (en) Glycerides with antibacterial properties
PT92051A (pt) Processo para a preparacao de compostos aza-alifaticos ciclicos com a funcao nitroxi, de compostos intermediarios e de composicoes farmaceuticas que contem estes compostos
KR860001790A (ko) 프로카테롤 안정화 방법
BG49274A3 (en) Method for preparing esters of 1- aminodicarbonate acid
KR880002879A (ko) (5r,6s,8r)-6-(1-하이드록시에틸)-2-(3r-피롤리딘-2-온-3-일) 티오페넴-3-카복실산
KR920011492A (ko) 시플로플록사신의 주사용 조성물 및 그 제조방법
KR830000211A (ko) 무라밀디펩타이드 유도체의 제조방법
ES2000879A6 (es) Un procedimiento para preparar una sal de acido inorganico de cloruro de n-(1(s)-etoxicarbonil-3-fenilpropil)-l-alanilo
KR890011901A (ko) 동물 성장 촉진제
KR830003875A (ko) 해식부착생물 방제방법
KR870006069A (ko) 스피로디포스포아미데이트-타입 화합물 및 그의 제조방법
KR890701118A (ko) 혈소판 감소증 예방 및 치료제
KR920009790A (ko) 광학 활성 고리상 아민 및 그의 광학 분할법
KR850005839A (ko) 에르고트 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application